Blood Glucose and Insulin Responses to Snack Food Products

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the effects of added food ingredients, when baked into a snack food product, on glycaemic index of the product and glycaemic and insulinemic responses to the product in healthy adults.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Glycaemic Responses to Cracker Snacks

NCT01687569

Glycaemic Response Measurements

COMPLETED NA

Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products

NCT02650674

Metabolic Disorder

COMPLETED NA

Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks

NCT06458946

Blood Glucose Blood Insulin

COMPLETED NA

Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers

NCT01870570

Glycaemia Insulinemia

COMPLETED NA

The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses

NCT02671214

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Study Focus 1:Glycaemic Index Study Focus 2:Glycaemic Response Study Focus 3:Insulinemic Response

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Test Food

Snack base

Group Type PLACEBO_COMPARATOR

Dietary Intervention

Intervention Type OTHER

Experimental Test Food 1

Snack Base containing ingredient 1

Group Type EXPERIMENTAL

Dietary Intervention

Intervention Type OTHER

Experimental Test Food 2

Snack base containing ingredient 2

Group Type EXPERIMENTAL

Dietary Intervention

Intervention Type OTHER

Experimental Test Food 3

Snack base containing ingredients 1 and 2

Group Type EXPERIMENTAL

Dietary Intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary Intervention

Intervention Type OTHER

Dietary Intervention

Intervention Type OTHER

Dietary Intervention

Intervention Type OTHER

Dietary Intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female (not less than 40% males or females
* Non-smoker
* Aged 18 to 55 years
* Have a body mass index between 18.5 to 29.99 kg/m2
* Fasting blood glucose (finger-stick) \>3.3 and \<5.6 mmol/L (Visit 2)
* Two-hour OGTT glucose (finger-stick) \<7.8 mmol/L (Visit 2)
* Willing and able to provide written informed consent

Exclusion Criteria

* Females who are lactating or may be pregnant or if of childbearing potential, are not taking adequate contraceptive precautions
* Any significant concurrent illness
* History of allergy likely to interfere with the study or known sensitivity to the test food or its ingredients
* Have assessed an investigational product for GI in the last 72 hours.
* Concurrent participation in any other safety study
* History of diabetes, hepatitis, AIDS, anaemia or a heart condition
* The use of any medication or dietary supplement which might, in the opinion of the principal investigator 1) make participation in the study dangerous to the subject, or 2) may affect the results.
* Had any type of gastrointestinal surgery, including gastric bypass
* Having consumed anything apart from plain water in the 12 hours prior to each test
* Have been medically diagnosed as having high blood pressure or heart disease

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes